|Applications||ICC/IF, IHC-P, WB|
Not tested in other applications.
|IHC (Formalin-fixed paraffin-embedded sections)||1:100-1:1000*
*Optimal dilutions/concentrations should be determined by the researcher.
|Predicted Target Size||34 kDa (note)
|Positive Controls||Jurkat , Raji , K562 , THP-1 , HL-60 , NCI-H929 , NIH-3T3 , JC , BCL-1|
(Please refer to the vial label for the specific concentration)|
|Purification||Purified by antigen-affinity chromatography.|
|Full Name||cytokine induced apoptosis inhibitor 1|
|Product Description||Rabbit Polyclonal antibody to CIAPIN1 (cytokine induced apoptosis inhibitor 1)|
|Background||CIAPIN1 is a cytokine-induced inhibitor of apoptosis with no relation to apoptosis regulatory molecules of the BCL2 (MIM 151430) or CASP (see MIM 147678) families. Expression of CIAPIN1 is dependent on growth factor stimulation (Shibayama et al., 2004 [PubMed 14970183]).[supplied by OMIM]|
|Synonyms||2810413N20Rik antibody, Anamorsin antibody, DRE2 antibody, PRO0915 antibody, CIAPIN1 antibody, predicted protein of HQ0915 antibody, fe-S cluster assembly protein DRE2 homolog antibody, cytokine-induced apoptosis inhibitor 1 antibody, cytokine induced apoptosis inhibitor 1 antibody|
|Cellular Localization||Cytoplasm |
|Immunogen||Full length human CIAPIN1 Recombinant protein.|
|Species Reactivity||Human, Mouse, Rat|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Predict Reactivity Note||Chimpanzee (99%), Bovine (90%)|